- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00860613
Medical Nutrition Therapy Program for Pregnant Women With Diabetes
March 11, 2009 updated by: Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes
Medical Nutrition Therapy Program for Pregnant Women With Diabetes: Evaluation of Two Different Dietary Strategies on Metabolic Control, Maternal and Fetal Nutritional Status and Cost Effectiveness.
No dietary strategies have been designed and proved for Mexican pregnant women with diabetes.
This is a randomized clinical trial of pregnant women with pregestational type 2 diabetes and gestational diabetes that were followed every two weeks until labor to assess the impact of the MNT program on metabolic control, maternal and fetal nutritional status and cost effectiveness.
Participants were randomly assigned to one of three medical nutrition therapy (MNT) groups: the MNT 1 group (n=38) received usual medical treatment, counseling from a nutritionist and diabetes educator, using carbohydrate counting (40-45% of carbohydrates)with an intensive educational component; MNT2 group (n=50) had the same treatment, but included only low-moderate glycemic index foods; and NO-MNT group (n=45) received the current hospital treatment.
All women will receive a glucose meter so they do self glucose monitoring (pre and postprandial) 2 times a weeks 6 times a day.
Weight gain, dietary consumption and glucose concentrations will be evaluated every two weeks.
Fetal outcomes (weight, length and presence of complications)will be measured at labor.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
162
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Mexico City
-
Mexico, Mexico City, Mexico, 11700
- Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- pregnant women with gestational diabetes (Freinkle´s classification: type A2 and B1) or pregestational type 2 diabetes.
- less than 30 weeks of gestation
- women who plan to attend their pregnancy at the institution (INPerIER)
Exclusion Criteria:
- women with type 1 pregestational diabetes or gestational diabetes type A1.
- women with multiple pregnancies
- women with renal or hepatic disease
- women who could not follow the dietary recommendations within the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: 1
women in this group received usual medical treatment and counseling from a nutritionist and diabetes educator.
They received a specific diet using carbohydrate counting (40-45% of carbohydrates)and a moderate energy restriction.
Weight gain, adequacy of diet, results of the self glucose monitoring, and ketonuria were evaluated every two weeks.
They also received education on diabetes, diet and glucose monitoring.
|
the dietary guidelines were based on the Nutrition Practice guidelines for gestational diabetes developed by the American Dietetic Association.
Dietary strategies were based on carbohydrate counting and/or restriction of high glycemic index foods.
Even carbohydrate distribution throughout the day was emphasized.
|
|
EXPERIMENTAL: 2
Women in this group received usual medical treatment and counseling from a nutritionist and diabetes educator.
The diet they received was based on carbohydrate counting (40-45% of carbohydrates), but recommended only low-moderate glycemic index foods.
Weight gain, adequacy of diet, results of the self glucose monitoring, and ketonuria were evaluated every two weeks.
They also received education on diabetes, diet and glucose monitoring.
|
the dietary guidelines were based on the Nutrition Practice guidelines for gestational diabetes developed by the American Dietetic Association.
Dietary strategies were based on carbohydrate counting and/or restriction of high glycemic index foods.
Even carbohydrate distribution throughout the day was emphasized.
|
|
NO_INTERVENTION: 3
women in this group received the current hospital treatment.
They did not receive any intervention except for the self glucose monitoring that they did every two weeks.
Weight gain and the results of the self glucose monitoring, were evaluated every two weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
metabolic control
Time Frame: every two weeks
|
every two weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
maternal nutritional status
Time Frame: every two weeks
|
every two weeks
|
|
fetal nutritional status
Time Frame: at labor
|
at labor
|
|
cost effectiveness
Time Frame: 3 years
|
3 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Felipe Vadillo-Ortega, M.D, PhD, Instituto Nacional de Perinatología Isidro Espionosa de los Reyes
- Principal Investigator: Otilia Perichart-Perera, M.S, RD, Instituto Nacional de Perinatología Isidro Espionosa de los Reyes
- Study Chair: Margie Balas-Nakash, B.S, Instituto Nacional de Perinatología Isidro Espionosa de los Reyes
- Study Chair: Adalberto Parra-Covarrubias, M.D, Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes
- Study Chair: Ameyalli Rodriguez-Cano, B.S, Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2004
Primary Completion (ACTUAL)
June 1, 2007
Study Completion (ACTUAL)
December 1, 2008
Study Registration Dates
First Submitted
March 11, 2009
First Submitted That Met QC Criteria
March 11, 2009
First Posted (ESTIMATE)
March 12, 2009
Study Record Updates
Last Update Posted (ESTIMATE)
March 12, 2009
Last Update Submitted That Met QC Criteria
March 11, 2009
Last Verified
March 1, 2009
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 212250-02091
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 2 Diabetes
-
University of North Carolina, Chapel HillAmerican Heart AssociationRecruitingType 2 Diabetes | Nutrition | Diabetes Type 2 | T2DM (Type 2 Diabetes Mellitus) | Diabetes Mellitis | T2DM | Diabetes EducationUnited States
-
Kaiser PermanenteThe Permanente Medical GroupEnrolling by invitationType 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type 2 Diabetes (T2D)United States
-
Endogenex, Inc.Not yet recruitingDiabetes Mellitus, Type 2 | Diabetes | Type 2 Diabetes Mellitus | Type 2 Diabetes | Type2diabetes
-
Medical University of GrazCompletedType 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type 2 Diabetes, Insulin RequiringAustria
-
ENBIOSIS BIOTECHNOLOGIESAydin Adnan Menderes University; Izmir University of Economics; Buca Seyfi Demirsoy... and other collaboratorsNot yet recruitingType 2 Diabetes | Diabetes Mellitus Type 2Turkey (Türkiye)
-
Endogenex, Inc.Not yet recruitingDiabetes Mellitus, Type 2 | Diabetes | Type 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type2Diabetes
-
University of SalamancaUniversity of Salamanca; Instituto Piaget; Escola Superior de Tecnologia da Saúde...Enrolling by invitationType 2 Diabetes Mellitus | Aging | Hyperglycemia Due to Type 2 Diabetes MellitusPortugal
-
University of PennsylvaniaNational Institute on Aging (NIA); American Heart AssociationRecruitingType 2 Diabetes Mellitus | Type 2 Diabetes | Type II Diabetes Mellitus | Pre-diabetes | Pre-diabetic | Type II Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type 2 Diabetes (T2DM) | Pre-diabetic StateUnited States
-
Instituto Nacional de Ciencias Medicas y Nutricion...Active, not recruiting
-
Steno Diabetes Center CopenhagenRecruitingDiabetes | Cognitive Impairment | Type 2 Diabetes | Diabetes Mellitus Type 2 | Cognitive Decline | Type 2 Diabetes Mellitus (T2DM)Denmark
Clinical Trials on medical nutrition therapy program
-
University of Alabama, TuscaloosaAcademy of Nutrition and DieteticsRecruitingBrain InjuriesUnited States
-
The University of Texas Medical Branch, GalvestonAmerican Diabetes AssociationRecruitingDiabetes Mellitus, Type 2United States
-
Hugo Mendieta ZeronFogarty International Center of the National Institute of Health; Instituto...CompletedGestational Weight GainMexico
-
St. Pölten University of Applied SciencesUniversity of Vienna; Danube University KremsActive, not recruitingOsteo Arthritis KneeAustria
-
Academy of Nutrition and DieteticsActive, not recruiting
-
The Third Xiangya Hospital of Central South UniversityUnknownDiabetes, GestationalChina
-
Ariel UniversitySheba Medical Center; Soroka University Medical CenterCompletedCardiovascular Diseases | Acute MIIsrael
-
Weill Medical College of Cornell UniversityTerminated
-
Hacettepe UniversityNot yet recruitingFibromyalgia | Fibromyalgia Syndrome, Primary | Fibromyalgia (FM)Turkey (Türkiye)
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)TerminatedPancreatic Cancer | Malnutrition | Lung Cancer | Prostate Cancer | Weight ChangesUnited States